A Study to Learn About How Itraconazole Affects the Blood Level of Study Medicine (PF-07817883) in Healthy Adults.

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 13, 2023

Primary Completion Date

July 10, 2023

Study Completion Date

July 10, 2023

Conditions
Healthy
Interventions
DRUG

PF-07817883

Single oral dose (period 1) or co-administered with itraconazole (period 2)

DRUG

Itraconazole

Interacting drug which will be given for 7 days in period 2

Trial Locations (1)

06511

New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY